• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life small airway outcomes in severe asthma patients receiving biologic therapies.

作者信息

Chan Rory, RuiWen Kuo Chris, Lipworth Brian

机构信息

Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, United Kingdom.

Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, United Kingdom.

出版信息

J Allergy Clin Immunol Pract. 2021 Jul;9(7):2907-2909. doi: 10.1016/j.jaip.2021.01.029. Epub 2021 Feb 2.

DOI:10.1016/j.jaip.2021.01.029
PMID:33545398
Abstract
摘要

相似文献

1
Real-life small airway outcomes in severe asthma patients receiving biologic therapies.接受生物疗法的重度哮喘患者的真实生活中小气道结局
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2907-2909. doi: 10.1016/j.jaip.2021.01.029. Epub 2021 Feb 2.
2
[COVID-19, severe asthma, and biologic].[新型冠状病毒肺炎、重度哮喘与生物制剂]
Rev Mal Respir. 2021 Apr;38(4):423-426. doi: 10.1016/j.rmr.2021.03.002. Epub 2021 Mar 18.
3
The use of biologic therapies for the management of pediatric asthma.生物疗法在小儿哮喘管理中的应用。
Pediatr Pulmonol. 2020 Mar;55(3):803-808. doi: 10.1002/ppul.24613. Epub 2019 Dec 27.
4
New insights into the treatment of severe asthma in children.儿童重症哮喘治疗的新见解。
Paediatr Respir Rev. 2015 Jun;16(3):167-73. doi: 10.1016/j.prrv.2014.07.006. Epub 2014 Aug 1.
5
The Long Road to Biologic Therapies for Asthma in Pediatric Patients.儿童哮喘生物疗法的漫长之路
Arch Bronconeumol (Engl Ed). 2021 Apr;57(4):249-250. doi: 10.1016/j.arbres.2020.08.003. Epub 2020 Sep 24.
6
Cost-Effectiveness of Biologic Therapies in Asthma in Spain.西班牙生物疗法治疗哮喘的成本效益
Arch Bronconeumol. 2023 Oct;59(10):621-622. doi: 10.1016/j.arbres.2023.05.007. Epub 2023 May 23.
7
Cycling biologic therapy for severe asthma.重度哮喘的循环生物疗法。
Pulmonology. 2022 Jan-Feb;28(1):65-67. doi: 10.1016/j.pulmoe.2021.07.009. Epub 2021 Oct 6.
8
Effect of Biologic Therapy on Total Body Composition in Severe Asthma.生物疗法对重度哮喘患者全身成分的影响。
Ann Am Thorac Soc. 2023 Dec;20(12):1825-1828. doi: 10.1513/AnnalsATS.202304-321RL.
9
Biologic Therapy and Novel Molecular Targets of Severe Asthma.生物疗法和严重哮喘的新型分子靶点。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):909-916. doi: 10.1016/j.jaip.2017.04.038.
10
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma.接受生物疗法治疗哮喘的患者中COVID-19疫苗反应降低。
Am J Respir Crit Care Med. 2022 May 15;205(10):1243-1245. doi: 10.1164/rccm.202111-2496LE.

引用本文的文献

1
Early benefit of mepolizumab on small airways in severe asthma: insights from the IMPOSE study.美泊利珠单抗对重度哮喘患者小气道的早期疗效：来自IMPOSE研究的见解
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00939-2024. eCollection 2025 May.
2
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge.在过敏性哮喘患者中，通过脉冲振荡法测量乙酰甲胆碱和吸入变应原激发后小气道生理的变化。
J Clin Med. 2025 Jan 30;14(3):906. doi: 10.3390/jcm14030906.
3
Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma.
生物疗法对重度2型高哮喘患者肺部新的不均匀性指标的影响。
BMJ Open Respir Res. 2025 Feb 8;12(1):e002721. doi: 10.1136/bmjresp-2024-002721.
4
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways.生物疗法在重度哮喘中的真实世界疗效：聚焦小气道
J Clin Med. 2024 Oct 2;13(19):5883. doi: 10.3390/jcm13195883.
5
Small airways in asthma: Pathophysiology, identification and management.哮喘中的小气道：病理生理学、识别与管理。
Chin Med J Pulm Crit Care Med. 2023 Sep 13;1(3):171-180. doi: 10.1016/j.pccm.2023.07.002. eCollection 2023 Sep.
6
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.抗 IL-5/IL-5R 治疗重度哮喘反应的特征：临床缓解的特征。
Front Immunol. 2024 Jan 23;15:1343362. doi: 10.3389/fimmu.2024.1343362. eCollection 2024.
7
Assessing the prognostic value of respiratory oscillometry in patients with difficult-to-treat asthma.评估呼吸振荡测量在难治性哮喘患者中的预后价值。
Sci Rep. 2023 Feb 11;13(1):2457. doi: 10.1038/s41598-023-29672-z.
8
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma.靶向小气道的单克隆抗体：重症哮喘生物治疗的新视角
Asthma Res Pract. 2022 Oct 17;8(1):6. doi: 10.1186/s40733-022-00088-2.
9
Impact of Biologic Therapy on the Small Airways Asthma Phenotype.生物疗法对小气道哮喘表型的影响。
Lung. 2022 Dec;200(6):691-696. doi: 10.1007/s00408-022-00579-2. Epub 2022 Oct 14.
10
Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study.成年中重度嗜酸性粒细胞性哮喘患者的振荡法支气管扩张剂反应：一项前瞻性队列研究。
Clin Exp Allergy. 2022 Sep;52(9):1118-1120. doi: 10.1111/cea.14185. Epub 2022 Jun 22.